Structure

Physi-Chem Properties

Molecular Weight:  506.36
Volume:  540.679
LogP:  4.602
LogD:  3.934
LogS:  -4.324
# Rotatable Bonds:  6
TPSA:  107.22
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.328
Synthetic Accessibility Score:  5.279
Fsp3:  0.9
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.843
MDCK Permeability:  9.410222992300987e-05
Pgp-inhibitor:  0.991
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.3
20% Bioavailability (F20%):  0.047
30% Bioavailability (F30%):  0.477

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.401
Plasma Protein Binding (PPB):  89.26638793945312%
Volume Distribution (VD):  0.782
Pgp-substrate:  2.4842920303344727%

ADMET: Metabolism

CYP1A2-inhibitor:  0.024
CYP1A2-substrate:  0.121
CYP2C19-inhibitor:  0.017
CYP2C19-substrate:  0.766
CYP2C9-inhibitor:  0.047
CYP2C9-substrate:  0.105
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.094
CYP3A4-inhibitor:  0.443
CYP3A4-substrate:  0.457

ADMET: Excretion

Clearance (CL):  2.561
Half-life (T1/2):  0.246

ADMET: Toxicity

hERG Blockers:  0.48
Human Hepatotoxicity (H-HT):  0.707
Drug-inuced Liver Injury (DILI):  0.06
AMES Toxicity:  0.006
Rat Oral Acute Toxicity:  0.976
Maximum Recommended Daily Dose:  0.988
Skin Sensitization:  0.922
Carcinogencity:  0.064
Eye Corrosion:  0.008
Eye Irritation:  0.053
Respiratory Toxicity:  0.953

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471903

Natural Product ID:  NPC471903
Common Name*:   (24S)-Ergost-22E-Ene-1Beta,3Beta,5Alpha,6Beta-Tetraol-25-Monoacetate
IUPAC Name:   [(E,3S,6R)-2,3-dimethyl-6-[(1R,3S,5R,6R,8S,9S,10S,13R,14S,17R)-1,3,5,6-tetrahydroxy-10,13-dimethyl-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]hept-4-en-2-yl] acetate
Synonyms:  
Standard InCHIKey:  GMKVQEJYVZLMNA-UTTFFMQTSA-N
Standard InCHI:  InChI=1S/C30H50O6/c1-17(8-9-18(2)27(4,5)36-19(3)31)22-10-11-23-21-15-26(34)30(35)16-20(32)14-25(33)29(30,7)24(21)12-13-28(22,23)6/h8-9,17-18,20-26,32-35H,10-16H2,1-7H3/b9-8+/t17-,18+,20+,21+,22-,23+,24+,25-,26-,28-,29+,30+/m1/s1
SMILES:  CC(C=CC(C)C(C)(C)OC(=O)C)C1CCC2C1(CCC3C2CC(C4(C3(C(CC(C4)O)O)C)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3289463
PubChem CID:   90681746
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003567] Ergostane steroids
          • [CHEMONTID:0001403] Ergosterols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32741 sarcophyton pauciplicatum Species Alcyoniidae Eukaryota n.a. Vietnamese soft coral n.a. PMID[24852121]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT983 Protein Complex Nuclear factor NF-kappa-B complex Homo sapiens EC50 = 8270.0 nM PMID[520661]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471903 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9121 High Similarity NPC219516
0.9011 High Similarity NPC473956
0.9011 High Similarity NPC475751
0.8947 High Similarity NPC300179
0.8947 High Similarity NPC102426
0.8901 High Similarity NPC109744
0.8854 High Similarity NPC208358
0.8842 High Similarity NPC475033
0.8842 High Similarity NPC475032
0.8791 High Similarity NPC475664
0.8763 High Similarity NPC155974
0.8763 High Similarity NPC289670
0.8763 High Similarity NPC475617
0.875 High Similarity NPC470067
0.875 High Similarity NPC470066
0.875 High Similarity NPC470068
0.8681 High Similarity NPC474657
0.8681 High Similarity NPC186145
0.8673 High Similarity NPC477054
0.866 High Similarity NPC473510
0.8646 High Similarity NPC476040
0.8646 High Similarity NPC476021
0.8646 High Similarity NPC474994
0.8646 High Similarity NPC210337
0.8646 High Similarity NPC316604
0.8614 High Similarity NPC472218
0.8614 High Similarity NPC472217
0.8614 High Similarity NPC472219
0.8602 High Similarity NPC10274
0.8586 High Similarity NPC474124
0.8586 High Similarity NPC222153
0.8571 High Similarity NPC474970
0.8571 High Similarity NPC477051
0.8571 High Similarity NPC477053
0.8571 High Similarity NPC470054
0.8571 High Similarity NPC6605
0.8571 High Similarity NPC477052
0.8557 High Similarity NPC477876
0.8557 High Similarity NPC119036
0.8557 High Similarity NPC477875
0.8542 High Similarity NPC253115
0.8542 High Similarity NPC304899
0.8542 High Similarity NPC88009
0.8539 High Similarity NPC202688
0.8539 High Similarity NPC154043
0.8539 High Similarity NPC60018
0.8529 High Similarity NPC284828
0.8529 High Similarity NPC5475
0.8529 High Similarity NPC173905
0.8529 High Similarity NPC472216
0.8511 High Similarity NPC275671
0.8511 High Similarity NPC97404
0.8511 High Similarity NPC41554
0.85 High Similarity NPC473543
0.8485 Intermediate Similarity NPC475344
0.8485 Intermediate Similarity NPC476471
0.8485 Intermediate Similarity NPC470053
0.8469 Intermediate Similarity NPC230546
0.8469 Intermediate Similarity NPC317019
0.8454 Intermediate Similarity NPC476893
0.8444 Intermediate Similarity NPC211135
0.8444 Intermediate Similarity NPC216420
0.8444 Intermediate Similarity NPC207013
0.8444 Intermediate Similarity NPC85095
0.8438 Intermediate Similarity NPC279974
0.8438 Intermediate Similarity NPC8774
0.8416 Intermediate Similarity NPC473199
0.8404 Intermediate Similarity NPC11216
0.8404 Intermediate Similarity NPC291484
0.8404 Intermediate Similarity NPC204188
0.8404 Intermediate Similarity NPC329596
0.8404 Intermediate Similarity NPC3345
0.8404 Intermediate Similarity NPC80561
0.84 Intermediate Similarity NPC473523
0.837 Intermediate Similarity NPC121981
0.837 Intermediate Similarity NPC201273
0.837 Intermediate Similarity NPC71520
0.837 Intermediate Similarity NPC269058
0.8367 Intermediate Similarity NPC476895
0.8352 Intermediate Similarity NPC475798
0.8352 Intermediate Similarity NPC127606
0.8352 Intermediate Similarity NPC299963
0.8351 Intermediate Similarity NPC292718
0.8351 Intermediate Similarity NPC111834
0.8351 Intermediate Similarity NPC227583
0.8351 Intermediate Similarity NPC306797
0.8351 Intermediate Similarity NPC12103
0.8351 Intermediate Similarity NPC288970
0.8351 Intermediate Similarity NPC169270
0.8351 Intermediate Similarity NPC98457
0.835 Intermediate Similarity NPC154085
0.835 Intermediate Similarity NPC43976
0.835 Intermediate Similarity NPC125361
0.835 Intermediate Similarity NPC296761
0.835 Intermediate Similarity NPC51925
0.8333 Intermediate Similarity NPC59530
0.8333 Intermediate Similarity NPC127718
0.8333 Intermediate Similarity NPC65402
0.8317 Intermediate Similarity NPC470064
0.8317 Intermediate Similarity NPC470062
0.8317 Intermediate Similarity NPC31430
0.8317 Intermediate Similarity NPC470058
0.8317 Intermediate Similarity NPC470057
0.8317 Intermediate Similarity NPC470043
0.8317 Intermediate Similarity NPC470059
0.8317 Intermediate Similarity NPC85593
0.8317 Intermediate Similarity NPC470061
0.8317 Intermediate Similarity NPC470060
0.8316 Intermediate Similarity NPC210268
0.83 Intermediate Similarity NPC154452
0.8298 Intermediate Similarity NPC105495
0.8298 Intermediate Similarity NPC470361
0.8283 Intermediate Similarity NPC476195
0.8283 Intermediate Similarity NPC254567
0.8283 Intermediate Similarity NPC474571
0.8283 Intermediate Similarity NPC38855
0.8265 Intermediate Similarity NPC274793
0.8265 Intermediate Similarity NPC477226
0.8265 Intermediate Similarity NPC278939
0.8265 Intermediate Similarity NPC473555
0.8265 Intermediate Similarity NPC471770
0.8261 Intermediate Similarity NPC266651
0.8261 Intermediate Similarity NPC164424
0.8252 Intermediate Similarity NPC472988
0.8252 Intermediate Similarity NPC38217
0.8247 Intermediate Similarity NPC276110
0.8247 Intermediate Similarity NPC241047
0.8242 Intermediate Similarity NPC193870
0.8242 Intermediate Similarity NPC141941
0.8235 Intermediate Similarity NPC220217
0.8235 Intermediate Similarity NPC119855
0.8235 Intermediate Similarity NPC186668
0.8229 Intermediate Similarity NPC26046
0.8218 Intermediate Similarity NPC10232
0.8218 Intermediate Similarity NPC472821
0.8218 Intermediate Similarity NPC196471
0.8218 Intermediate Similarity NPC187302
0.8218 Intermediate Similarity NPC189588
0.8218 Intermediate Similarity NPC97487
0.8218 Intermediate Similarity NPC474575
0.8211 Intermediate Similarity NPC123252
0.8211 Intermediate Similarity NPC219937
0.8211 Intermediate Similarity NPC194485
0.8211 Intermediate Similarity NPC53890
0.82 Intermediate Similarity NPC476132
0.82 Intermediate Similarity NPC96784
0.82 Intermediate Similarity NPC21064
0.82 Intermediate Similarity NPC256247
0.82 Intermediate Similarity NPC476896
0.82 Intermediate Similarity NPC121072
0.82 Intermediate Similarity NPC235920
0.82 Intermediate Similarity NPC49532
0.8191 Intermediate Similarity NPC473436
0.8191 Intermediate Similarity NPC160304
0.8191 Intermediate Similarity NPC133588
0.8191 Intermediate Similarity NPC474668
0.819 Intermediate Similarity NPC65167
0.819 Intermediate Similarity NPC470076
0.8182 Intermediate Similarity NPC157739
0.8182 Intermediate Similarity NPC477854
0.8172 Intermediate Similarity NPC94462
0.8172 Intermediate Similarity NPC299068
0.8163 Intermediate Similarity NPC475178
0.8163 Intermediate Similarity NPC210717
0.8163 Intermediate Similarity NPC103165
0.8163 Intermediate Similarity NPC276103
0.8163 Intermediate Similarity NPC54248
0.8163 Intermediate Similarity NPC299654
0.8155 Intermediate Similarity NPC234160
0.8152 Intermediate Similarity NPC255882
0.8144 Intermediate Similarity NPC3359
0.8144 Intermediate Similarity NPC277399
0.8144 Intermediate Similarity NPC474922
0.8137 Intermediate Similarity NPC471293
0.8132 Intermediate Similarity NPC472504
0.8132 Intermediate Similarity NPC30166
0.8125 Intermediate Similarity NPC130840
0.8125 Intermediate Similarity NPC234335
0.8125 Intermediate Similarity NPC189520
0.8119 Intermediate Similarity NPC136816
0.8113 Intermediate Similarity NPC44537
0.8111 Intermediate Similarity NPC206735
0.8111 Intermediate Similarity NPC236237
0.8111 Intermediate Similarity NPC13554
0.8111 Intermediate Similarity NPC322313
0.8111 Intermediate Similarity NPC102253
0.81 Intermediate Similarity NPC477655
0.81 Intermediate Similarity NPC167974
0.8095 Intermediate Similarity NPC177047
0.8095 Intermediate Similarity NPC472214
0.8095 Intermediate Similarity NPC472215
0.8081 Intermediate Similarity NPC261807
0.8065 Intermediate Similarity NPC470360
0.8061 Intermediate Similarity NPC476894
0.8058 Intermediate Similarity NPC470055
0.8058 Intermediate Similarity NPC477877
0.8058 Intermediate Similarity NPC472655
0.8058 Intermediate Similarity NPC470056
0.8043 Intermediate Similarity NPC110778
0.8043 Intermediate Similarity NPC113978

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471903 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8111 Intermediate Similarity NPD7525 Registered
0.7895 Intermediate Similarity NPD7524 Approved
0.7838 Intermediate Similarity NPD7516 Approved
0.7822 Intermediate Similarity NPD7638 Approved
0.7766 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD7327 Approved
0.7748 Intermediate Similarity NPD7328 Approved
0.7745 Intermediate Similarity NPD7640 Approved
0.7745 Intermediate Similarity NPD7639 Approved
0.7677 Intermediate Similarity NPD6399 Phase 3
0.766 Intermediate Similarity NPD6695 Phase 3
0.7576 Intermediate Similarity NPD7637 Suspended
0.757 Intermediate Similarity NPD6881 Approved
0.757 Intermediate Similarity NPD6899 Approved
0.7547 Intermediate Similarity NPD5739 Approved
0.7547 Intermediate Similarity NPD6675 Approved
0.7547 Intermediate Similarity NPD6402 Approved
0.7547 Intermediate Similarity NPD7128 Approved
0.7544 Intermediate Similarity NPD8296 Approved
0.7544 Intermediate Similarity NPD8033 Approved
0.7544 Intermediate Similarity NPD8380 Approved
0.7544 Intermediate Similarity NPD8335 Approved
0.7544 Intermediate Similarity NPD8379 Approved
0.7544 Intermediate Similarity NPD8378 Approved
0.7477 Intermediate Similarity NPD5697 Approved
0.7456 Intermediate Similarity NPD8294 Approved
0.7456 Intermediate Similarity NPD8377 Approved
0.7455 Intermediate Similarity NPD8297 Approved
0.7431 Intermediate Similarity NPD6883 Approved
0.7431 Intermediate Similarity NPD7290 Approved
0.7431 Intermediate Similarity NPD7102 Approved
0.7407 Intermediate Similarity NPD7320 Approved
0.74 Intermediate Similarity NPD8035 Phase 2
0.74 Intermediate Similarity NPD8034 Phase 2
0.7391 Intermediate Similarity NPD6932 Approved
0.7387 Intermediate Similarity NPD4632 Approved
0.7364 Intermediate Similarity NPD6649 Approved
0.7364 Intermediate Similarity NPD6847 Approved
0.7364 Intermediate Similarity NPD8130 Phase 1
0.7364 Intermediate Similarity NPD6617 Approved
0.7364 Intermediate Similarity NPD6650 Approved
0.7364 Intermediate Similarity NPD6869 Approved
0.7363 Intermediate Similarity NPD6942 Approved
0.7363 Intermediate Similarity NPD7339 Approved
0.7347 Intermediate Similarity NPD7750 Discontinued
0.7345 Intermediate Similarity NPD7115 Discovery
0.734 Intermediate Similarity NPD6930 Phase 2
0.734 Intermediate Similarity NPD6931 Approved
0.7339 Intermediate Similarity NPD6373 Approved
0.7339 Intermediate Similarity NPD6014 Approved
0.7339 Intermediate Similarity NPD6013 Approved
0.7339 Intermediate Similarity NPD6012 Approved
0.7339 Intermediate Similarity NPD6372 Approved
0.7333 Intermediate Similarity NPD5344 Discontinued
0.732 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD5701 Approved
0.7304 Intermediate Similarity NPD6319 Approved
0.7297 Intermediate Similarity NPD6882 Approved
0.7283 Intermediate Similarity NPD6933 Approved
0.7248 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD6011 Approved
0.7241 Intermediate Similarity NPD7503 Approved
0.7234 Intermediate Similarity NPD7645 Phase 2
0.7234 Intermediate Similarity NPD6929 Approved
0.7216 Intermediate Similarity NPD4786 Approved
0.7212 Intermediate Similarity NPD6083 Phase 2
0.7212 Intermediate Similarity NPD6084 Phase 2
0.7191 Intermediate Similarity NPD4267 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD7514 Phase 3
0.7143 Intermediate Similarity NPD4225 Approved
0.7143 Intermediate Similarity NPD7507 Approved
0.7128 Intermediate Similarity NPD6697 Approved
0.7128 Intermediate Similarity NPD7145 Approved
0.7128 Intermediate Similarity NPD6114 Approved
0.7128 Intermediate Similarity NPD6118 Approved
0.7128 Intermediate Similarity NPD6115 Approved
0.7117 Intermediate Similarity NPD4634 Approved
0.7107 Intermediate Similarity NPD7319 Approved
0.7103 Intermediate Similarity NPD7632 Discontinued
0.7097 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7087 Intermediate Similarity NPD7748 Approved
0.7075 Intermediate Similarity NPD5286 Approved
0.7075 Intermediate Similarity NPD4696 Approved
0.7075 Intermediate Similarity NPD5285 Approved
0.7065 Intermediate Similarity NPD6926 Approved
0.7065 Intermediate Similarity NPD6924 Approved
0.7064 Intermediate Similarity NPD6008 Approved
0.7059 Intermediate Similarity NPD7087 Discontinued
0.7059 Intermediate Similarity NPD6079 Approved
0.7059 Intermediate Similarity NPD7492 Approved
0.7059 Intermediate Similarity NPD7515 Phase 2
0.7054 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD6683 Phase 2
0.7048 Intermediate Similarity NPD4755 Approved
0.7048 Intermediate Similarity NPD7902 Approved
0.7043 Intermediate Similarity NPD6009 Approved
0.703 Intermediate Similarity NPD6051 Approved
0.703 Intermediate Similarity NPD5328 Approved
0.7025 Intermediate Similarity NPD7736 Approved
0.7021 Intermediate Similarity NPD6116 Phase 1
0.7021 Intermediate Similarity NPD6925 Approved
0.7021 Intermediate Similarity NPD5776 Phase 2
0.701 Intermediate Similarity NPD3667 Approved
0.7009 Intermediate Similarity NPD6054 Approved
0.7 Intermediate Similarity NPD6412 Phase 2
0.7 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6616 Approved
0.699 Remote Similarity NPD4202 Approved
0.6979 Remote Similarity NPD7332 Phase 2
0.6975 Remote Similarity NPD7604 Phase 2
0.697 Remote Similarity NPD6893 Approved
0.6949 Remote Similarity NPD5983 Phase 2
0.6944 Remote Similarity NPD5226 Approved
0.6944 Remote Similarity NPD5225 Approved
0.6944 Remote Similarity NPD4633 Approved
0.6944 Remote Similarity NPD5211 Phase 2
0.6944 Remote Similarity NPD5224 Approved
0.6942 Remote Similarity NPD7078 Approved
0.693 Remote Similarity NPD8133 Approved
0.6923 Remote Similarity NPD7101 Approved
0.6923 Remote Similarity NPD7100 Approved
0.6916 Remote Similarity NPD4700 Approved
0.6916 Remote Similarity NPD6648 Approved
0.6915 Remote Similarity NPD6117 Approved
0.6907 Remote Similarity NPD6902 Approved
0.69 Remote Similarity NPD3618 Phase 1
0.6891 Remote Similarity NPD6370 Approved
0.6882 Remote Similarity NPD4784 Approved
0.6882 Remote Similarity NPD4785 Approved
0.6881 Remote Similarity NPD5175 Approved
0.6881 Remote Similarity NPD5174 Approved
0.6875 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6864 Remote Similarity NPD6059 Approved
0.686 Remote Similarity NPD6336 Discontinued
0.6857 Remote Similarity NPD5695 Phase 3
0.6852 Remote Similarity NPD5223 Approved
0.6848 Remote Similarity NPD7152 Approved
0.6848 Remote Similarity NPD7150 Approved
0.6848 Remote Similarity NPD7151 Approved
0.6838 Remote Similarity NPD6335 Approved
0.6822 Remote Similarity NPD5696 Approved
0.6818 Remote Similarity NPD5141 Approved
0.6814 Remote Similarity NPD5955 Clinical (unspecified phase)
0.681 Remote Similarity NPD6274 Approved
0.6807 Remote Similarity NPD6016 Approved
0.6807 Remote Similarity NPD6015 Approved
0.6804 Remote Similarity NPD7509 Discontinued
0.6803 Remote Similarity NPD8293 Discontinued
0.6792 Remote Similarity NPD5221 Approved
0.6792 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6792 Remote Similarity NPD5222 Approved
0.6786 Remote Similarity NPD6686 Approved
0.6765 Remote Similarity NPD6672 Approved
0.6765 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6765 Remote Similarity NPD5737 Approved
0.6762 Remote Similarity NPD7900 Approved
0.6762 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6752 Remote Similarity NPD6317 Approved
0.675 Remote Similarity NPD5988 Approved
0.6739 Remote Similarity NPD7144 Approved
0.6739 Remote Similarity NPD7143 Approved
0.6735 Remote Similarity NPD6898 Phase 1
0.6733 Remote Similarity NPD6409 Approved
0.6733 Remote Similarity NPD5330 Approved
0.6733 Remote Similarity NPD7521 Approved
0.6733 Remote Similarity NPD6684 Approved
0.6733 Remote Similarity NPD7334 Approved
0.6733 Remote Similarity NPD7146 Approved
0.6731 Remote Similarity NPD6411 Approved
0.6729 Remote Similarity NPD5173 Approved
0.6702 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6701 Remote Similarity NPD4195 Approved
0.6699 Remote Similarity NPD4753 Phase 2
0.6698 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6697 Remote Similarity NPD4159 Approved
0.6695 Remote Similarity NPD6313 Approved
0.6695 Remote Similarity NPD6314 Approved
0.6667 Remote Similarity NPD4243 Approved
0.6667 Remote Similarity NPD6908 Approved
0.6667 Remote Similarity NPD6868 Approved
0.6667 Remote Similarity NPD6909 Approved
0.6637 Remote Similarity NPD4730 Approved
0.6637 Remote Similarity NPD4729 Approved
0.6636 Remote Similarity NPD4697 Phase 3
0.6633 Remote Similarity NPD4748 Discontinued
0.6633 Remote Similarity NPD4820 Approved
0.6633 Remote Similarity NPD4819 Approved
0.6633 Remote Similarity NPD5790 Clinical (unspecified phase)
0.6633 Remote Similarity NPD4821 Approved
0.6633 Remote Similarity NPD4822 Approved
0.663 Remote Similarity NPD6923 Approved
0.663 Remote Similarity NPD6922 Approved
0.661 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6607 Remote Similarity NPD4768 Approved
0.6607 Remote Similarity NPD4767 Approved
0.6602 Remote Similarity NPD6903 Approved
0.6577 Remote Similarity NPD4754 Approved
0.6571 Remote Similarity NPD5281 Approved
0.6571 Remote Similarity NPD5284 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data